BLLN BillionToOne, Inc.

NASDAQ

$123.08

BillionToOne, Inc. (BLLN) is expected to report earnings on December 10, 2026, after the market close. The consensus earnings estimate is $0.18 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +17.0% since its last earnings release on August 5, 2026.

BillionToOne Reported In-line with Estimates, Reaffirms

Wednesday, August 5, 2026 · 4:05 PM ET

3rd Quarter, Sep 2026

Thursday · 4:05 PM ET

Earnings Whisper

-

vs $0.18

Rev est $117M

Volatility

Enter your expectations below to reveal the current volatility.

Trend Analysis

Expectation

Earnings

Price action

Signals

Score

Sentiment

Grade

Life Cycle

Call Analysis

Earnings-AVWAP $99.53

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About BillionToOne, Inc.

BillionToOne is a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all.

Sector

Healthcare

Industry

Medical Labs & Research

Charts powered in part by Lightweight Charts™ by TradingView.